Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
07:45am, Saturday, 04'th Jan 2025
Now that we've shut the door on 2024, it's useful to look back at some of the best -- and, on the flip side, some of the worst -- performers of the year on the stock market. Many outliers were in the
2 Nasdaq Artificial Intelligence (AI) Stocks to Buy Before They Soar as Much as 153% in 2025, According to Certain Wall Street Analysts
03:02am, Saturday, 04'th Jan 2025
The Nasdaq Composite (^IXIC 1.77%) has climbed consistently higher over the past couple of years as technology investors have sought to profit from the economic recovery, the rapid adoption of artific
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:20pm, Friday, 03'rd Jan 2025
Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on de
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
05:15pm, Friday, 03'rd Jan 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 2, 2025, the Compensation Committee of Puma's Board of Directors approved
BriaCell Announces Proposed Effective Date of Share Consolidation
05:05pm, Friday, 03'rd Jan 2025
PHILADELPHIA and VANCOUVER, British Columbia, Jan. 03, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage bio
Why We Lightened Up On Nasdaq 100 Exposure To End The Year
04:59pm, Friday, 03'rd Jan 2025
With cross currents jostling the markets and a knowledge of history, we were quick to sell. And quick to buy back.
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 03'rd Jan 2025
SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, d
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:10pm, Friday, 03'rd Jan 2025
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 03'rd Jan 2025
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on January 2, 2025, the Compensation Committee of the company's Board of Directors granted t
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 03'rd Jan 2025
BOSTON, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on December 31, 2024
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 03'rd Jan 2025
QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic canc
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 03'rd Jan 2025
SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent s
Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
02:34pm, Friday, 03'rd Jan 2025
SAN DIEGO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase
Alset Inc. Announces Closing of $1.5 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
02:08pm, Friday, 03'rd Jan 2025
BETHESDA, MD, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ: AEI) (the “Company”), a diversified company engaged through its subsidiaries in the development of EHome communities and real es
Nasdaq Surges Over 1%; Cerence Shares Spike Higher
12:02pm, Friday, 03'rd Jan 2025
U.S. stocks traded higher midway through trading, with the Nasdaq Composite surging more than 1% on Friday.
